To date, the Medicines Patent Pool has signed agreements with ten patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment.

Negotiating public health-driven licences with patent holders, sublicensing to generic manufacturers and product developers, and supporting access to those treatments in LMICs, are the core work of the Medicines Patent Pool.

Below is an overview of all our licensing and sublicensing agreements. For more information, click on the product, patent holder, generic partner or product developer you are interested in.



Patent Holder

Generic Manufacturers and Other Licensees



MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders

This website uses cookies to ensure you get the best experience on our website. Learn More